Awiqli News

Novo Nordisk India has launched Awiqli, the first once-weekly basal insulin for diabetes, aiming to reduce injections from daily to weekly for the over 101 mill

डेनमार्क की दवा कंपनी नोवो नॉर्डिस्क ने भारत में दुनिया की पहली सप्ताह में एक बार दी जाने वाली बेसल इंसुलिन 'Awiqli' लॉन्च की है, जिसकी कीमत ₹2611 है। यह टाइप-1

India has received the world's first once-a-week insulin, Awiqli, developed by Novo Nordisk.

India has received Novo Nordisk's Awiqli, a new once-weekly insulin injection for adults with diabetes, significantly reducing the frequency of basal insulin do

Novo Nordisk has launched its once-weekly insulin, Awiqli, in India at ₹261 per week, making India the seventh market for the drug. This initiative aims to addr

Novo Nordisk has launched Awiqli, a new weekly insulin shot, in India, priced at ₹261 for a 70-unit dose.

Novo Nordisk has launched Awiqli, a new once-weekly basal insulin injection, in India to provide an alternative to daily injections for diabetes patients and ad

Novo Nordisk has introduced Awiqli, a once-a-week insulin priced at Rs 2,600 per pen, significantly reducing the frequency of injections for patients.